Rigel Pharmaceuticals (RIGL) Gross Margin (2018 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Gross Margin of 92.17% for Q1 2026, up 44.0% year-over-year from 64.01% in Q1 2025, and up 0.77% quarter-over-quarter from 91.47% in Q4 2025.
Rigel Pharmaceuticals (RIGL) Gross Margin (2018 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Gross Margin history runs 9 years deep, the most recent figure standing at 92.17% for Q1 2026.
- In Q1 2026, Gross Margin rose 44.0% year-over-year to 92.17%; the TTM figure through Mar 2026 stood at 93.39% (up 375.0% YoY), while the FY2025 annual figure was 93.33%, up 373.0% from the prior year.
- Gross Margin for Q1 2026 stood at 92.17%, up from 91.47% in the prior quarter.
- The five-year high for Gross Margin was 99.33% in Q4 2022, with the low at 85.49% in Q3 2024.
- The 5-year median for Gross Margin is 93.16% (2025), against an average of 93.9%.
- The sharpest annual moves came in 2024 and 2025: Gross Margin slumped 1000 bps in 2024, then jumped 767 bps in 2025.
- Rigel Pharmaceuticals' Gross Margin stood at 99.33% in 2022, then retreated by 10 bps to 89.41% in 2023, then advanced by 1 bps to 89.95% in 2024, then rose by 2 bps to 91.47% in 2025, then rose by 1 bps to 92.17% in 2026.
- Business Quant data shows RIGL's Gross Margin at 92.17% in Q1 2026, 91.47% in Q4 2025, and 93.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 89.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.17% |
| Mar 31, 2026 | 92.17% |
| Dec 31, 2025 | 91.47% |
| Sep 30, 2025 | 93.16% |
| Jun 30, 2025 | 95.57% |
| Mar 31, 2025 | 91.73% |
| Dec 31, 2024 | 89.95% |
| Sep 30, 2024 | 85.49% |
| Jun 30, 2024 | 92.38% |
| Mar 31, 2024 | 93.14% |
| Dec 31, 2023 | 89.41% |
| Sep 30, 2023 | 95.49% |
| Jun 30, 2023 | 96.00% |
| Mar 31, 2023 | 96.25% |
| Dec 31, 2022 | 99.33% |
| Sep 30, 2022 | 98.88% |
| Jun 30, 2022 | 96.53% |
| Mar 31, 2022 | 99.28% |
| Dec 31, 2021 | 97.61% |
| Sep 30, 2021 | 99.30% |